ArthroCare To Pay $30M To End $400M Securities Fraud Probe
Texas-based surgical instrument maker ArthroCare Corp. agreed Tuesday to pay $30 million and enter into a deferred prosecution agreement, ending a U.S. Department of Justice probe over senior executives' scheme to...To view the full article, register now.
Already a subscriber? Click here to view full article